| Literature DB >> 25046632 |
Jonny Crocker1, Jamie Bartram2.
Abstract
Drinking water quality monitoring programs aim to support provision of safe drinking water by informing water quality management. Little evidence or guidance exists on best monitoring practices for low resource settings. Lack of financial, human, and technological resources reduce a country's ability to monitor water supply. Monitoring activities were characterized in Cambodia, Colombia, India (three states), Jordan, Peru, South Africa, and Uganda according to water sector responsibilities, monitoring approaches, and marginal cost. The seven study countries were selected to represent a range of low resource settings. The focus was on monitoring of microbiological parameters, such as E. coli, coliforms, and H2S-producing microorganisms. Data collection involved qualitative and quantitative methods. Across seven study countries, few distinct approaches to monitoring were observed, and in all but one country all monitoring relied on fixed laboratories for sample analysis. Compliance with monitoring requirements was highest for operational monitoring of large water supplies in urban areas. Sample transport and labor for sample collection and analysis together constitute approximately 75% of marginal costs, which exclude capital costs. There is potential for substantive optimization of monitoring programs by considering field-based testing and by fundamentally reconsidering monitoring approaches for non-piped supplies. This is the first study to look quantitatively at water quality monitoring practices in multiple developing countries.Entities:
Mesh:
Substances:
Year: 2014 PMID: 25046632 PMCID: PMC4113879 DOI: 10.3390/ijerph110707333
Source DB: PubMed Journal: Int J Environ Res Public Health ISSN: 1660-4601 Impact factor: 3.390
Data collection activities.
| Site | Interviews | Observations * |
|---|---|---|
| Cambodia | 20 | 3 |
| Colombia | 6 | 2 |
| India—Maharashtra | 11 | 4 |
| India—Uttar Pradesh | 11 | 4 |
| India—West Bengal | 6 | 3 |
| Jordan | 13 | 3 |
| Peru | 14 | 2 |
| South Africa | 20 | 4 |
| Uganda | 13 | 2 |
* Observations include laboratories, treatment plants, and sample collection trips.
Parameters used to calculate monitoring as prescribed and estimate monitoring as practiced.
| Prescribed Testing * | Extrapolated Testing * |
|---|---|
| Monitoring standards | Tests/laboratory |
| Settlements by size | Tests/technician |
| Water supplies by size | Tests/region |
| Compliance with standards | |
| Laboratories | |
| Settlements by size | |
| Water supplies by size | |
| Population census |
* Data sources used to calculate prescribed testing and extrapolated monitoring as practiced are listed by country in Supplement 2.
Parameters used to calculate costs for each monitoring scenario.
| Test Materials | Labor | Transportation |
|---|---|---|
| Test cost * | Staffing | Vehicles type and number |
| Tests/technician | Hours/day sampling | |
| Samples/sampler | Distances traveled | |
| Salaries * | Sampler reimbursements |
* When country-specific costs were not captured during field work, costs cited in literature were used. The costs used for each parameter by country are listed in Supplement 2.
Test materials cost figures from published literature.
| Test Type | Indicator | Materials Cost | Source |
|---|---|---|---|
| H2S test strips | Presence-absence | $0.62 | [ |
| Multiple tube | MPN | $1.62 | [ |
| Colilert kit | MPN | $6.50 | [ |
| Petrifilm | Colony forming units (CFU) per 1 mL | $1.04 | [ |
| Membrane filtration | CFU per 100 mL | $2.25 | [ |
| Various | Presence-absence | $0.60–$5.00 | [ |
| Various | MPN or CFU | $0.50–$7.50 | [ |
Descriptive statistics for study sites.
| Country | Population | Access to an Improved Drinking Water Source (%) | Population Living in a Rural Setting (%) | GDP Per Capita (2010$) |
|---|---|---|---|---|
| India ** | 1,156,897,766 | 88 | 70.5 | 976 |
| Uttar Pradesh * | 166,198,000 | 81 | 79.2 | 323 |
| West Bengal * | 80,176,000 | 73 | 72.0 | 618 |
| Maharashtra * | 96,879,000 | 72 | 57.6 | 905 |
| Jordan ** | 6,113,000 | 98 | 17.0 | 2654 |
| Colombia ** | 46,043,696 | 92 | 24.2 | 3648 |
| Peru ** | 29,797,694 | 82 | 25.4 | 3880 |
| Uganda ** | 32,369,558 | 67 | 85.2 | 403 |
| Cambodia ** | 14,521,275 | 61 | 79.0 | 598 |
| South Africa ** | 49,052,489 | 91 | 43.0 | 5826 |
* [12], ** [13].
Figure 1Scenario prevalence across nine study sites.
Figure 2Prescribed and extrapolated levels of monitoring by scenario.
Figure 3Compliance with monitoring requirements by country.
Figure 4Marginal cost per test for three scenarios averaged across nine sites.
Prescribed and extrapolated levels of testing and testing costs by scenario averaged across nine study sites.
| Parameter | Large Supply Operational | Small Supply Operational | Surveillance | |
|---|---|---|---|---|
| Prescribed |
|
|
|
|
| Cost/test (2010$) | 7.31 [5.43, 10.4] ** | 7.44 [1.10, 10.11] | 7.09 [4.79, 9.14] | |
| Tests/1,000 capita | 2.53 [1.20, 6.34] | 8.28 [0.61, 28.4] | 12.1 [1.68, 33.4] | |
| Cost/1000 capita (2010$) | 18.0 [6.52, 39.3] | 45.4 [5.87, 204] | 84.6 [8.03, 270] | |
| Extrapolated |
|
|
|
|
| Compliance (%) *** | 77.2 [5.31, 167] | 59.7 [0.27, 170] | 53.3 [11.0, 100] | |
| Tests/1000 capita | 1.73 [0.064, 5.42] | 1.84 [0.078, 5.38] | 4.74 [0.68, 21.5] | |
| Cost/1000 capita (2010$) | 12.9 [0.41, 40.7] | 15.6 [0.081, 49.2] | 29.2 [4.02, 125] | |
* “Sites” refers to countries and Indian states; ** Bracketed values are minimums and maximums; *** Compliance refers to extrapolated number of samples analyzed compared to number of test required.